UK markets close in 26 minutes

Enveric Biosciences, Inc. (ENVB)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.9127-0.0213 (-2.28%)
As of 11:03AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Gross profit
-
-
-
0
0
Operating expenses
Research development
8,627
7,252
8,028
4,789
174.083
Selling general and administrative
18,418
10,700
11,606
20,499
5,322
Total operating expenses
27,459
18,297
19,961
25,945
5,617
Operating income or loss
-27,459
-18,297
-19,961
-25,945
-5,617
Interest expense
10.239
-
5.249
10.316
445.25
Total other income/expenses net
-31,884
1,030
9.3
-30,477
-802.109
Income before tax
-59,354
-17,263
-19,957
-56,432
-6,865
Income tax expense
28.913
28.913
-1,486
-7,455
0
Income from continuing operations
-51,899
-17,292
-18,471
-48,977
-6,865
Net income
-51,919
-17,311
-18,504
-48,977
-6,865
Net income available to common shareholders
-52,104
-17,459
-18,800
-48,977
-6,865
Basic EPS
-11.51
-
-13.00
-103.69
-59.50
Diluted EPS
-11.51
-
-13.00
-103.69
-59.50
Basic average shares
2,109
-
1,446
472.343
115.071
Diluted average shares
2,109
-
1,446
472.343
115.071